COHERUS BIOSCIENCES I
0.8200
07-十一月-24 15:59:58
15 分钟延时
股票
+0.0962
+13.29%
今日范围
0.7610 - 0.9550
ISIN
N/A
来源
NASDAQ
-
Coherus Prices Public Offering of Common Stock
16 5月 2023 06:50:00 条件 Nasdaq GlobeNewswire
-
Coherus Announces Proposed Public Offering of Common Stock
15 5月 2023 16:01:00 条件 Nasdaq GlobeNewswire
-
Coherus BioSciences Reports First Quarter 2023 Financial Results and Business Highlights
08 5月 2023 16:05:02 条件 Nasdaq GlobeNewswire
-
Coherus BioSciences to Present at Upcoming Investor Conferences in May
04 5月 2023 16:30:00 条件 Nasdaq GlobeNewswire
-
Coherus BioSciences to Report First Quarter 2023 Financial Results on May 8, 2023
01 5月 2023 16:07:00 条件 Nasdaq GlobeNewswire
-
27 4月 2023 08:05:00 条件 Nasdaq GlobeNewswire
-
Coherus BioSciences Reports Fourth Quarter and Full Year 2022 Results
06 3月 2023 16:01:00 条件 Nasdaq GlobeNewswire
-
FDA Approves UDENYCA® Autoinjector
06 3月 2023 08:00:00 条件 Nasdaq GlobeNewswire
-
Coherus BioSciences to Present at Upcoming Investor Conferences in March
01 3月 2023 08:25:00 条件 Nasdaq GlobeNewswire
-
Coherus BioSciences to Report Fourth Quarter and Full Year 2022 Financial Results on March 6, 2023
28 2月 2023 08:25:00 条件 Nasdaq GlobeNewswire
-
13 2月 2023 08:25:00 条件 Nasdaq GlobeNewswire
-
Coherus BioSciences Announces New Employment Inducement Grants
03 2月 2023 17:30:09 条件 Nasdaq GlobeNewswire
-
09 1月 2023 08:20:00 条件 Nasdaq GlobeNewswire
-
Coherus BioSciences Management to Present at the 41st Annual J.P. Morgan Healthcare Conference
04 1月 2023 07:01:00 条件 Nasdaq GlobeNewswire
-
Coherus BioSciences Reports Third Quarter 2022 Results and Provides Business Update
08 11月 2022 16:01:00 条件 Nasdaq GlobeNewswire
-
Coherus BioSciences to Report Third Quarter 2022 Financial Results on November 8th, 2022
01 11月 2022 07:30:00 条件 Nasdaq GlobeNewswire
-
12 10月 2022 07:30:00 条件 Nasdaq GlobeNewswire
-
Coherus to Launch CIMERLI™ (ranibizumab-eqrn) in the United States on October 3, 2022
19 9月 2022 07:30:00 条件 Nasdaq GlobeNewswire